Adrenal incidentalomas are a common clinical dilemma and are seen on 4% of abdominal CT scans (1), with incidence rising with increased utility of cross-sectional imaging (2, 3) . Investigation of these lesions aims to exclude malignancy and hormonally active lesions. The current standard for management is the AACE guidelines as summarised in figure 1.
Zeiger et al states that of all adrenal incidentalomas detected, 80% are non-functional adenomas, 6% functional adenomas, 5% phaeochromocytomas, <5% adrenocortical carcinomas and 2.5% metastases (2) . A literature review by Cawood et al suggested that the conversion rates of benign adenomas to functional or malignant lesions was <1% and <0.2% respectively (4).
BACKGROUND
This study was performed to: Table 1 summarises the diagnoses and outcome in 145 adrenal incidentalomas. In figure 2 , the incidence of each diagnosis in this study is compared to the literature review.
METHODS
Radiology results:  65 (45%) of the initial scans were diagnostic of a benign adenoma (CT density <10HU)  Of these, 27 had additional diagnostic imaging -MRI or CT, all of which confirmed the original diagnosis.  43 (30%) were indeterminate on the original scan, but were deemed to be benign adenomas following further imaging (In and out of phase MRI, CT density <10HU, CT contrast washout >60% at 10 minutes).  7 (5%) had indeterminate detection scans with no repeat imaging (comorbidity or failure to attend).  All malignant lesions, metastases and phaeochromocytomas had abnormal initial imaging.  The single case of Conn's syndrome, had an indeterminate initial and repeat scan.
Biochemical results:  135 (93%) of the cohort was hormonally inactive.  All 5 phaeochromocytomas had raised urinary metanephrines.  7 (5%) had a 9am cortisol >100 following 1mg dexamethasone, none of whom had symptoms/signs consistent with cortisol excess.  all were deemed to be normal after further investigation  3 (2%) had abnormal renin: aldosterone levels (>72).
 1 diagnosed as Conn's adenoma (also hypertensive and hypokalaemic)  2 on-going investigation/monitoring  2 males had elevated DHEAS levels, both of whom had abnormal imaging.
 1 was found to have a phaeochromocytoma
RESULTS
None of those tumours considered to be benign adenomas on imaging proved to be hormonally active and endocrine screening may therefore not be necessary. All hormonally active and malignant lesions had abnormal or indeterminate imaging.
This study suggests that in patients who have a) no symptoms or signs, b) are normotensive, c) are normokalaemic and d) have imaging features consistent with a benign adrenal adenoma, further investigation is unrewarding. 
CONCLUSION
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